History Mission Strategic plan Role The FAMHP also ensures that … Our core business Our organisation Organisation chart Our vision and values Vision and ambition Values Commitments by federal administrations Our stakeholders Partners FAMHP customer charter Partners receiving financial support from the FAMHP The FAMHP and European projects Disclaimer Transparency Social media Conditions for reuse (Creative Commons-0 licence)
27/09/2024 PRAC September 2024 – Recommendation for metamizole and to minimise the risk associated with medroxyprogesterone acetate
19/09/2024 Limited availability of Zypadhera powder and solvent for suspension with prolonged release used for injections: recommendations update
04/09/2024 Limited availability of medicinal product based on peginterferon alfa-2a, solution for injection: recommendations for physicians (-specialists) and (hospital) pharmacists.